Amesite Inc. (Nasdaq: AMST) Presenting at The Microcap Conference on January 29
Amesite Inc. (Nasdaq: AMST), an AI technology company, announces its participation in The Microcap Conference 2025 at the Borgata Hotel Spa & Casino in Atlantic City from January 28-30, 2025. CEO Dr. Ann Marie Sastry will deliver a corporate presentation on January 29 at 2:30 PM ET and conduct one-on-one meetings with investors.
The presentation will focus on recent developments of the company's NurseMagic™ app, an AI-powered mobile application designed for nursing professionals and home health care workers. The app aims to streamline daily tasks, enhance efficiency, improve patient communication, and support career development. Dr. Sastry will also discuss the company's growth strategy and monetization plans in both B2C and B2B markets.
Amesite Inc. (Nasdaq: AMST), un'azienda tecnologica di intelligenza artificiale, annuncia la sua partecipazione alla Microcap Conference 2025 che si terrà al Borgata Hotel Spa & Casino di Atlantic City dal 28 al 30 gennaio 2025. Il CEO Dr. Ann Marie Sastry presenterà l'azienda il 29 gennaio alle 14:30 ET e terrà incontri individuali con gli investitori.
La presentazione si concentrerà sugli sviluppi recenti dell'app NurseMagic™, un'applicazione mobile alimentata da intelligenza artificiale progettata per professionisti dell'assistenza infermieristica e lavoratori della salute a domicilio. L'app mira a semplificare le attività quotidiane, aumentare l'efficienza, migliorare la comunicazione con i pazienti e supportare lo sviluppo professionale. Il Dr. Sastry discuterà anche della strategia di crescita dell'azienda e dei piani di monetizzazione nei mercati B2C e B2B.
Amesite Inc. (Nasdaq: AMST), una empresa de tecnología de IA, anuncia su participación en la Microcap Conference 2025 en el Borgata Hotel Spa & Casino en Atlantic City del 28 al 30 de enero de 2025. La CEO Dra. Ann Marie Sastry realizará una presentación corporativa el 29 de enero a las 2:30 PM ET y llevará a cabo reuniones individuales con inversores.
La presentación se centrará en los desarrollos recientes de la aplicación NurseMagic™, una aplicación móvil impulsada por IA diseñada para profesionales de enfermería y trabajadores de cuidados a domicilio. La app tiene como objetivo simplificar las tareas diarias, aumentar la eficiencia, mejorar la comunicación con los pacientes y apoyar el desarrollo profesional. La Dra. Sastry también discutirá la estrategia de crecimiento de la empresa y los planes de monetización en mercados B2C y B2B.
Amesite Inc. (Nasdaq: AMST), 인공지능 기술 회사,는 2025년 1월 28일부터 30일까지 Atlantic City의 Borgata Hotel Spa & Casino에서 열리는 Microcap Conference 2025에 참여할 것이라고 발표했습니다. CEO Dr. Ann Marie Sastry는 1월 29일 오후 2시 30분 ET에 기업 발표를 진행하고 투자자들과의 일대일 회의를 가질 예정입니다.
발표는 간호 전문가와 가정 건강 관리자를 위해 설계된 AI 기반 모바일 애플리케이션 NurseMagic™의 최근 개발에 초점을 맞출 것입니다. 이 앱은 일상 작업을 간소화하고, 효율성을 높이며, 환자와의 소통을 개선하고, 경력 개발을 지원하는 것을 목표로 합니다. Dr. Sastry는 또한 B2C 및 B2B 시장에서의 회사 성장 전략과 수익화 계획에 대해 논의할 것입니다.
Amesite Inc. (Nasdaq: AMST), une entreprise de technologie IA, annonce sa participation à la Microcap Conference 2025 au Borgata Hotel Spa & Casino à Atlantic City du 28 au 30 janvier 2025. La PDG Dr. Ann Marie Sastry fera une présentation d'entreprise le 29 janvier à 14h30 ET et organisera des réunions individuelles avec les investisseurs.
La présentation mettra l'accent sur les récents développements de l'application NurseMagic™, une application mobile alimentée par l'IA, conçue pour les professionnels de la santé et les travailleurs des soins à domicile. L'application vise à simplifier les tâches quotidiennes, améliorer l'efficacité, renforcer la communication avec les patients et soutenir le développement professionnel. Dr. Sastry discutera également de la stratégie de croissance de l'entreprise et des plans de monétisation sur les marchés B2C et B2B.
Amesite Inc. (Nasdaq: AMST), ein KI-Technologieunternehmen, gibt seine Teilnahme an der Microcap Conference 2025 im Borgata Hotel Spa & Casino in Atlantic City vom 28. bis 30. Januar 2025 bekannt. CEO Dr. Ann Marie Sastry wird am 29. Januar um 14:30 Uhr ET eine Unternehmenspräsentation halten und Einzelgespräche mit Investoren führen.
Die Präsentation wird sich auf die aktuellen Entwicklungen der NurseMagic™-App konzentrieren, einer KI-unterstützten mobilen Anwendung, die für Pflegefachkräfte und Gesundheitsdienstleister im Heimdienst entwickelt wurde. Die App zielt darauf ab, tägliche Aufgaben zu optimieren, die Effizienz zu steigern, die Kommunikation mit Patienten zu verbessern und die berufliche Entwicklung zu unterstützen. Dr. Sastry wird auch über die Wachstumsstrategie des Unternehmens und die Monetarisierungspläne für die B2C- und B2B-Märkte sprechen.
- None.
- None.
CEO to Provide Update on Company’s NurseMagic™ App
DETROIT, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Amesite, Inc. (Nasdaq:AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference is taking place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
Amesite’s CEO, Dr. Ann Marie Sastry, will deliver a corporate presentation at 2:30 PM ET today, January 29, and engage in one-on-one meetings with institutional and individual investors to discuss the company’s recent developments with its NurseMagic™ app, growth strategy, and monetization in B2C and B2B pathways.
NurseMagic™ is an AI-powered mobile application designed to assist nursing professionals and home health care workers by streamlining various aspects of their daily tasks. Developed by Amesite Inc., the app offers a suite of tools aimed at enhancing efficiency, improving patient communication, and supporting career development.
About Amesite Inc.
Amesite Inc. (Nasdaq: AMST) is a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions. Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional needs. NurseMagic™, the company’s mobile app for health and care professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations.
Forward-Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact
MJ Clyburn
TraDigital IR
clyburn@tradigitalir.com
FAQ
What is Amesite's NurseMagic™ app and what features does it offer?
When and where is Amesite (AMST) presenting at The Microcap Conference 2025?
What will be discussed during Amesite's (AMST) presentation at The Microcap Conference?